Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sierra oncology, inc. symbols : Glaxf save search
Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors
Published: 2023-11-28 (Crawled : 21:00) - biospace.com/
UNCY | $1.15 2.68% 2.61% 140K
|
Professional, Scientific, and T...
|
| O: -6.96%
H: 7.9%
C: 3.35%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: -0.51%
H: 0.96%
C: 0.54%
GERN | $3.69 3.07% 2.98% 9.6M
|
Health Technology
|
| O: -1.05%
H: 2.65%
C: 1.06%
corporation
Global Cancer Vaccine Industry Worth $13.4 Billion by 2030: Use of Nanosensors in Diagnosing Cancer Expected to Create Ample Opportunities for Key Players
Published: 2023-06-27 (Crawled : 10:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: -0.91%
H: 0.56%
C: -0.5%
MRNA | News S | $103.45 -0.33% -0.33% 2M
|
Health Technology
|
| O: 0.03%
H: 0.37%
C: 0.18%
DVAX | $11.44 -0.43% -0.44% 2.5M
|
Health Technology
|
| O: 0.08%
H: 1.31%
C: 0.77%
vaccine expected cancer global
Investor Alert - The M&A Class Action Firm is Investigating the Merger - ATRS, SRRA, SAIL, MSP, CDK, VWTR
Published: 2022-04-18 (Crawled : 22:00) - prnewswire.com
SAIL | $65.24 -0.03%
|
Technology Services
|
| O: -0.3%
H: 0.14%
C: 0.09%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: -0.52%
H: 0.63%
C: -0.15%
MSP 4 | $35.18 0.51%
|
Technology Services
|
| O: 0.0%
H: 0.29%
C: 0.17%
DHI | $145.74 -0.21% 0.17% 3.1M
|
Consumer Durables
|
| O: 0.35%
H: 3.95%
C: 3.52%
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: -0.36%
IESC | $116.96 -3.08% -3.17% 94K
|
Industrial Services
|
| O: 0.68%
H: 1.74%
C: 1.09%
HALO M | $38.02 -0.94% -0.95% 700K
|
Health Technology
|
| O: 0.57%
H: 2.81%
C: 1.26%
CDK | $54.76 -0.15% 0.07%
|
Commercial Services
|
| O: 0.06%
H: 0.02%
C: -0.04%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -0.18%
H: 0.36%
C: 0.0%
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn
Published: 2022-04-13 (Crawled : 09:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.76%
H: 0.35%
C: 0.35%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: -0.24%
H: 0.45%
C: 0.39%
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 37.85%
H: 0.9%
C: 0.5%
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.